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Abstract
Background: The aim of this study was to estimate the prevalence and factors associated with Trichomonas
vaginalis (T. vaginalis) among female sex workers (FSW) in Togo in 2017. A cross-sectional bio-behavioral study was
conducted from August to October 2017 using a respondent-driven sampling method in four cities in Togo.
Method: A standardized questionnaire was used to record socio-demographic data and sexual behavior patterns. T.
vaginalis detection by molecular biology tests was performed using Allplex STI Essential Assay which detect also 6
others micro-organisms. A blood sample was drawn and serological test using SD Bioline Duo VIH/Syphilis rapid
test was performed for Human immunodeficiency virus (HIV) and syphilis testing.
Results: A total of 310 FSW with median age 25 years, interquartile range (IQR) [21–32 years] were included. The
prevalence of T. vaginalis was 6.5% (95%CI = [4.1–9.9]) and, overall, prevalence of other STI ranged from 4.2%
(95%CI = [2.3–7.2]) for N. gonorrhoeae to 10.6% (95% CI = [7.5–14.7]) for HIV. Binary logistic regression was conducted
to assess factors associated with T. vaginalis infection. Living in Lomé (aOR = 3.19; 95%CI = [1.11–11.49]), having had
sexual intercourse before the age of 18 (aOR = 5.72; 95%CI = [1.13–10.89]), and being infected with C. trachomatis
(aOR = 3.74; 95%CI = [2.95–12.25]) were factors associated with T. vaginalis among FSW.
Conclusion: The prevalence of T. vaginalis infection using molecular test was low among FSW in Togo. Extensive
studies are needed to confirm and to better understand the epidemiology of T. vaginalis among this population
and in other populations in Togo.
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Background
Trichomonas vaginalis (T. vaginalis) is the most com-
mon, curable parasitic sexually transmitted infection
(STI) worldwide affecting both men and women [1]. In
2012, 143 million cases of T. vaginalis had been
diagnosed in women aged 15–49 years worldwide, in-
cluding 17.5 million in Africa [2]. In 2016, Bayesian
meta-analysis was used to generate estimates of the
prevalence of STI. In women, prevalence estimates for
T. vaginalis was 5.3%, for Chlamydia Trachomatis (C.
trachomatis) 3.8%, for Neisseria gonorrhoeae (N. gonor-
rhoeae) 0.9%, and for syphilis 0.5%. In men, prevalence
estimates for T. vaginalis was 0.6% which was very low
compared to C. trachomatis (2.7%) and N. gonorrhoeae
(0.7%) [3]. T. vaginalis vaginal infection in the African
region are estimated at 42.8 million, and in the same
region, this infection is ten times more common in
women than in men [4]. In Africa, data on clinical pres-
entation and microbiological factors associated with T.
vaginalis infection are limited [5]. In contrast, multiple
studies on T. vaginalis have been performed in other
regions of the world [6–9].
As with most STI, T. vaginalis infection is largely asso-
ciated with an increased risk in Human immunodefi-
ciency virus (HIV) acquisition [10–13]. In a meta-
analysis of 11 studies, T. vaginalis infection was a risk
factor for HIV (95% CI 1.3 to 1.7; p < 0.001) [14]. Data
on T. vaginalis are mainly described in pregnant women
[15, 16] and few data are available on key populations as
populations with high risk of HIV infection. In Lagos
(Nigeria), the prevalence of T. vaginalis infection among
HIV-positive and HIV-negative pregnant women was
10.0 and 8.1%, respectively (p = 0.559) [17]. In Togo,
HIV prevalence is five times higher (10.6%) among
female sex workers (FSW) [18]) than in the general
population (2.3% [19]).
To our knowledge, no study on T. vaginalis infection
using molecular technique has been conducted in Togo,
especially among FSW. The aim of this study was to es-
timate the prevalence and factors associated with T.
vaginalis among FSW in Togo.
Methods
Study design and recruitment
Between August and October 2017, a cross-sectional
study was conducted among FSWs in Togo. Covering
57,000 km2, Togo is a country located in West Africa
with 7.6 million inhabitant in 2018. The HIV preva-
lence in the general population was estimated at 2.3%
in 2018 [19].
Participants were included through the respondent-
driven sampling method [20, 21]. FSWs were defined as
women who had sex for money as compensation in the
previous 12 months. Additional inclusion criteria were
being ≥18 years old, living in Togo for more than 3
months, and giving written informed consent [22, 23].
Study procedures and detection of T. vaginalis and other
STI
A standardized questionnaire adapted from a Family
Health International (FHI) 360 validated guide for bio-
behavioral surveys was administered during a face-to
face interview to collect information regarding socio-
demographic characteristics, risky sexual behaviors.
Cervical swabs collection and venous blood sample as
well as biological analyses were described in detail else-
where [18].
Statistical analysis
Descriptive analyses were performed and results were
presented with frequency tabulations and percentages.
Prevalence were estimated with their 95% confidence
interval (95%CI). Chi-square or Fisher’s exact tests were
used to compare categorical variables. In multivariable
analysis, logistic regression was conducted to identify
factors associated with T. vaginalis infection.
Associations in the regression model were expressed
as adjusted odds ratio (AOR) using all variables that had
p < 0.20 in the univariable regression. Predictor variables
were selected as those found to be relevant according to
the literature review. All computations were conducted
using R© version 3.4.3 software and the level of signifi-
cance was set at 5%.
Results
Socio-demographic and clinical characteristics
A total of 310 FSW with median age of 25 years, inter-
quartile range (IQR) [21–32 years] participated in the
study. Almost half (46.2%) of them were over 25 years
old while around one third (30.3%) were between 21 and
25 years old. More than seven out of ten FSW (76.1%)
reported living with their partner and the majority had
at least a secondary school level (74.5%). Almost 80% of
FSW had their first sexual intercourse before the age of
18. Sociodemographic characteristics according to geo-
graphic area are summarized in Table 1 and none of the
differences observed were statistically significant.
Prevalence of T. vaginalis infection and others STI
Table 2 summarizes the prevalence of sexually transmit-
ted infections among FSW in Togo in 2017. The preva-
lence of T. vaginalis was 6.5% (95%CI = [4.1–9.9]) and,
overall, prevalence of other STI ranged from 4.2%
(95%CI = [2.3–7.2]) for N. gonorrhoeae to 10.6%
(95%CI = [7.5–14.7]) for HIV.
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Factors associated with T. vaginalis infection among FSW
After multivariable adjustment, three factors had a sta-
tistically significant positive association with T. vaginalis
infection among FSW. FSW living in Lomé (aOR = 3.19;
95%CI = [1.11–11.49]), those having had sexual inter-
course before the age of 18 (aOR = 5.72; 95%CI = [1.13–
10.89]), and those being infected with C. trachomatis
(aOR = 3.74; 95%CI = [2.95–12.25]) were more likely to
have a T. vaginalis infection (Table 3).
Discussion
This study provided an update on the epidemiology of
T. vaginalis infection and revealed a prevalence of 6.5%
among FSW in Togo. The overall prevalence of other
STI were 10.6, 5.5, 6.1 and 4.2% for HIV, M. genitalium,
C. Trachomatis and N. gonorrhoeae infections respect-
ively. Among FSW population, risk factors associated
with T. vaginalis infection were the geographic area
(capital city, Lomé), lower age at first intercourse and in-
fection with C. Trachomatis.
The prevalence of T. vaginalis infection among FSW
reported in this study is approximately similar to those
reported across other countries, as reported by other
studies. In Rwanda, a descriptive cross-sectional study
conducted in 2015 among 1168 FSW reported a preva-
lence of 11.9% [24]. In a 2-year longitudinal study con-
ducted among 350 Kenyan FSW, baseline prevalence of
T. vaginalis was 9.2% [25]. In an another prospective co-
hort study among 352 South African youths including
lesbian, gay, bisexual, transgender, and queer (LGBTQ),
an overall prevalence of 4.8% has been reported (8.1%
among female and 0.7% among male participants) [26].
In a prospective, interventional cohort study of FSW
aged 18 to 25 years in Ouagadougou among 321 HIV-
uninfected FSW the prevalence of T. vaginalis was 3%
[27]. The prevalence of T. vaginalis however was report-
edly lower in the general population of women in a pro-
spective study among 302 pregnant women conducted
in 2011 in Togo which found a prevalence of T. vagina-
lis of 3.7% [28]. There is a need for additional effort to-
wards the prevention of STI among FSW, which is an
occupational risk in this line of work that could be pre-
vented by the correct and consistent use of condoms.
Among FSW, the correct and consistent use of condoms
is still a challenge that requires more attention [29, 30].
No other STI, except from C. trachomatis was associ-
ated with T. vaginalis infection. There was no associ-
ation between T. vaginalis and HIV infection which is
contrary to results from previous studies. In South
Africa, an association was found between T. vaginalis
and HIV positive infection (OR = 1.6; p = 0.041) [5]. An-
other study conducted in Ouagadougou found an








Age (years), n (%) 0.053
[18–20] 38 (28.8) 35 (19.7) 73 (23.5)
[21–25] 43 (32.6) 51 (28.7) 94 (30.3)
> 25 51 (38.6) 92 (51.6) 143 (46.2)
Living with a partner, n (%) 0.879
Yes 100 (75.8) 136 (76.4) 236 (76.1)
No 32 (24.2) 42 (23.6) 74 (23.9)
Education level, n (%) 0.490
Primary school or below 38 (28.8) 41 (23.0) 79 (25.5)
Secondary school 83 (62.9) 119 (66.9) 202 (65.1)
At least high school 11 (8.3) 18 (10.1) 29 (9.4)
Age at first intercourse (years), n (%) 0.126
≤ 15 41 (31.1) 47 (26.4) 88 (28.4)
]15–18] 72 (54.5) 89 (50.0) 161 (51.9)
> 18 19 (14.4) 42 (23.6) 61 (19.7)
*Chi square test
Table 2 Prevalence of Trichomonas vaginalis and other STI
among female sex workers in Togo (2017)
N n Prevalence (%) 95CI%
Trichomonas vaginalis 310 20 6.5 [4.1–9.9]
HIV 310 33 10.6 [7.5–14.7]
Mycoplasma genitalium 310 17 5.5 [3.3–8.8]
Chlamydia trachomatis 310 19 6.1 [3.8–9.6]
Neisseria gonorrhoeae 310 13 4.2 [2.3–7.2]
95%CI 95% Confidence interval; HIV Human immunodeficiency virus
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association between HIV infection and T. vaginalis
(aOR = 9.63; 95% CI: [2.93 to 31.59]) [27]. A meta- ana-
lysis of T. vaginalis and HIV infection in sub-Saharan
Africa found that individuals infected with T. vaginalis
were 1.5 times more likely to acquire HIV compared to
individuals not infected with T. vaginalis [14]. However,
as corroborated by other studies, C. trachomatis infec-
tion (adjusted Prevalence Ratio (aPR) = 8.53; 95%CI =
[3.35–21.71]) was identified as a risk factor of T. vagina-
lis infection in Kenya [25]. In the same study, a signifi-
cant association was reported between positive HIV
status and T. vaginalis infection (aPR = 3.01; 95% CI =
[1.45–6.24]). In another study conducted in China, C.
trachomatis was associated to T. vaginalis infection
(aOR = 2.4 [95% CI: 1.37–4.14]) [31]. The lack of the
association between HIV and T vaginalis in our study
could be explained by the large access to antiretroviral
treatment for the FSW when identified HIV positive,
however this information is not collected. In addition,
the lack of association between HIV, M. genitalium, C.
trachomatis and N. gonorrhoeae infections could be ex-
plained by several factors including the limited sample
size of the study population. Studies could further ex-
plore the relationship between other STI infection and
T. vaginalis in high-risk women taking into account the
impact of antiretroviral therapy.
Early age at first intercourse was associated with posi-
tive T. vaginalis infection in our study. Similar results
have been reported by other studies such as in China
among 734 FSW (aOR = 1.9 [95% CI: 1.11–3.30]) for
Table 3 Factors associated with Trichomonas vaginalis among female sex workers in Togo, 2017 (N = 310)
Univariable Multivariable
OR 95%CI p-value aOR 95%CI p-value
Age (years)
≤ 24 – –
> 24 0.58 [0.22–1.45] 0.249 –
Geographic area
Others – –
Lomé 3.16 [1.13–11.24] 0.044 3.19 [1.11–11.49] 0.045
Living with a partner
Yes – –
No 0.54 [0.12–1.68] 0.343 –
Education level
Primary school or below – –
Secondary school 1.10 [0.41–3.51] 0.857 –
High school 0.53 [0.03–3.47] 0.568 –
Age at first sex (years)
> 18 – –
≤ 18 4.96 [1.01–8.90] 0.122 5.72 [1.13–10.89] 0.029
HIV status
Negative – –
Positive 0.42 [0.02–2.15] 0.411 –
Mycoplasma genitalium
Negative – –
Positive 2.04 [0.31–8.00] 0.368 –
Neisseria gonorrhoeae
Negative – –
Positive 1.22 [0.07–6.71] 0.853 –
Chlamydia trachomatis
Negative – –
Positive 4.58 [1.20–14.44] 0.014 3.74 [2.95–12.25] 0.038
OR Odds Ratio; aORadjusted Odds Ratio.
95%CI 95% Confidence interval.
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starting age in commercial sex before 20 years [31] and
in India in 2006 (aOR = 2.09; 95%CI: 1.09–4.00) [32].
Overall prevalence of T. vaginalis among sexually active
women aged 15–30 years was 8.5 and 14.4% for women
under 50 years at first sex. Another study of a nationally
representative sample of 9844 respondents aged 18 to
26 years in the United States found a significantly higher
risk of T. vaginalis infection among adolescents and
young adults who were younger at the time of their first
sexual intercourse [33]. Also consistent with our result,
a cross-sectional study conducted in four cities in sub–
Saharan Africa (Kisumu, Kenya; Ndola, Zambia; Coto-
nou, Benin and Yaoundé, Cameroon) among a random
sample of 8000 adults (2000 in each city), aged 15–49
years showed a prevalence of T. vaginalis respectively of
29.3% in Kisumu, 34.3% in Ndola, 3.2% in Cotonou and
17.6% in Yaoundé. Early sexual debut (before age 15)
was a significantly risk factor associated with T. vaginalis
infection in women in Ndola (Zambia) [34]. Specific in-
terventions are needed to delay the age of the first sexual
intercourse among FSW and in general population.
Most of studies on T. vaginalis in Africa are conducted
in pregnant women and report high prevalence in this
population. A nested case-control study in Kenya among
pregnant women reported a T. vaginalis infection preva-
lence of 35.4% (n = 79) [35], while in Nigeria [36] and
South Africa [37], the prevalence of T. vaginalis infec-
tion among pregnant women was 18.7 and 15.0%, re-
spectively. Hence, in many studies in sub-Saharan
Africa, the prevalence of T. vaginalis among women in
the general population, especially among pregnant
women is higher than that of FSW, as reported in this
study. One plausible explanation could be the use of mo-
lecular biology test, which is among the most specific for
T. vaginalis detection compared to other tests that could
be less accurate. Another possible explanation could be
the systematic use of treatment in case of genital infec-
tion for FSW. In Togo, in case of STI symptoms, syn-
dromic approach which includes the use of
azithromycin, ceftriaxone, doxycycline, metronidazole as
first line treatment are systematically used in care cen-
ters. However, additional and comparative studies are
needed to shed light on interventions or hypotheses that
could explain it.
To our knowledge, this was the first study reporting
prevalence of T. vaginalis infection and other STI
among FSW in Togo. Another strength of this study
includes the use of a sensitive laboratory assay for the
reliable detection of T. vaginalis infection and the re-
lationship with HIV. Finally, our study was the first
to assess factors associated with T. vaginalis among
FSW in Togo and to provide useful information in
order to design specific interventions within these
populations.
There were few limitations to this study including
the lack of data on treatment use among study partic-
ipants, which may have certainly impacted observed
STI prevalence. In Togo, syndromic approach is used
for the treatment of STI among FSW and in general
population. Furthermore, the standardized question-
naire submitted to participants can be biased (mem-
ory bias and social desirability bias) by the fact that it
was based on self-reporting and may not reflect the
overall sexual activity. Additionally, due to the cross-
sectional nature of this analysis, we are unable to
analyze the causality and temporality of the associa-
tions between T. vaginalis infection and other factors.
Conclusion
The prevalence of T. vaginalis infection using molecular
test among FSW in Togo was low. However, extensive
studies are needed to confirm and better understand the
epidemiology of T. vaginalis in these populations in
Togo. Comprehensive health promotion programs for
FSW and active surveillance that include preventive edu-
cation are needed.
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